维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

9篇 您的检索式：作者名="Ear US"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin显示文摘	Bhattacharyya A Ear US Koller BH	2000	J Biol Chem2000，275，23：	1
	2	The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin显示文摘	Bhattacharyya A Ear US Koler BH	2000	J Biol Chem2000，275，23：	1
	3	The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin显示文摘	Bhattacharyya A Ear US Koler BH	2000	J Biol Chem2000，275，23：	1
	4	The breast cancer susceptibilitygene BRCAl is required for subnuclear assembly of Rad51 and survival following treatment with the DNA crosslinkinaagent cisplatin显示文摘	Bhattacharyya A Ear US Koler BH	2000	J Biol Chem2000，275，23：	1
	5	The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross--linking agent cisplatin显示文摘	Bhattacharyya A Ear US Koter BH	2009	Biol ehem2009，275，23：	1
	6	The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin 显示文摘	Bhattacharyya A Ear US Koller BH	2000	J Biol Chem2000，275，23：	1
	7	The breast cancer sus-ceptibility gene BRCA1 is required for subnuclear assembly ofRad51 and survival following treatment with the DNA cross-link-ing agent cisplatin显示文摘	Bhattacharyya A Ear US Koller BH	2000	J Biol Chem2000，275，23：	1
	8	The breast cancer susceptibility gene BRCA1 is required for subnuelear assembly of Rad51 and survival following treatment with the DNA cross-linking agent eisplatin 显示文摘	Bhattacharyya A Ear US Koller BH	2000	J Biol Chem2000，275，23：	1
	9	The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Bad51 and survival following treatment with the DNA cross-linking agent cisplatin 显示文摘	Bhattazharyya A Ear US KoUer BH et 81	2000	J Biol Chem2000，275，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费